Bharat Immunologicals & Biologicals Corporation Ltd Q2 Results

  • BSE: 524663
  • NSE: -
  • ISIN: INE994B01014
  • Sector: Biotechnology & Drugs
BSE
16.920.19 (1.14%)
Volume11.45 K
Updated: Mon 20 Jul, 2026 | 15:29:50
NSE
This stock is not traded on NSE
Today: 16.71
17.18
52-Wk: 14.10
23.90

Technical Trends

Long Term
Considers price movement over the last 6 months

Long Term
Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available
  • Bearish
  • Moderately Bearish
  • Neutral
  • Moderately Bullish
  • Bullish

Insight: Trends unavailable at the moment.

Q2 Results Highlights

  • Total Income
    ₹0.00 Cr.
    (NA%)
  • Operating Profit
    ₹-4.72 Cr.
    (86.19%)
  • Profit After Tax
    ₹-4.92 Cr.
    (59.52%)
  • Operating Margin
    NA%
    (NA%)
Note: Comparison is on YoY basis

Quarterly - Bharat Immunologicals & Biologicals Corporation Ltd Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 23Jun 23QoQ CompSep 22YoY Comp
Total Operating Expense 4.724.358.61%29.02-83.72%
Depreciation/ Amortization 0.030.030.00%0.04-6.03%
Operating Income -4.72-4.358.61%-2.5486.19%
Net Income -4.92-4.597.22%-3.0859.52%
Net Income Before Taxes -6.65-5.9711.37%-3.9667.87%
Other Operating Expenses Total 0.710.4270.78%0.659.30%
Total Revenue 0.000.000.00%26.480.00%
Diluted Normalized EPS -1.14-1.067.55%-0.7160.56%

EQUITY QUICK LINKS

FROM MARKETS

RELATED LINKS

Recommended For You

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe

      Trending Now In Market

        ✕

        Wait for it…

        Log in to our website to save your bookmarks. It'll just take a moment.

        ✕

        Wait for it…

        Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.